Olopatadine-d6 (hydrochloride)

• UNSPSC Description:

  Olopatadine-d6 (ALO4943A-d6; KW4679-d6) hydrochloride is deuterium-labeled Olopatadine (hydrochloride) (HY-B0426A)[1].

• Target Antigen:

  Endogenous Metabolite; Histamine Receptor; Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  GPCR/G Protein;Immunology/Inflammation;Metabolic Enzyme/Protease;Neuronal Signaling;Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Smiles:

  O=C(O)CC1=CC=C(C/2=C1)OC([2H])([2H])C3=C([2H])C([2H])=C([2H])C([2H])=C3C2=C\CCN(C)C.Cl

• Molecular Weight:

  379.91

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Smith K A, et al. Soil and environmental analysis[M]. Marcel Dekker Incorporated, 2000.|[3]Fan T W M, et al. Stable isotope-resolved metabolomics and applications for drug development[J]. Pharmacology & therapeutics, 2012, 133(3): 366-391.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported